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Background: Synthetic bone graft substitutes such as bioactive glass (BG) material are developed in order to
achieve successful bone regeneration. Zn plays an important role in the proper bone growth, development,
and maintenance of healthy bones.
Aims: This study aims to evaluate in vivo the performance therapy of zinc-doped bioactive glass (BG-Zn) and
its applications in biomedicine.
Methods: Female Wistar rats were ovariectomized. BG and BG-Zn were implanted in the femoral condyles of
Wistar rats and compared to that of control group. Grafted bone tissues were carefully removed to evaluate
the oxidative stress status, histomorphometric profile, mechanical property, and mineral bone distribution by
using inductively coupled plasma optical emission spectrometry.
Results: A significant decrease of thiobarbituric acidreactive substances was observed after BG-Zn im-
plantation. Superoxide dismutase, catalase (CAT), and glutathione peroxidase (GPx) activities significantly
increased in ovariectomized group implanted with Zinc-doped bioactive glass (OVX-BG-Zn) as compared
to ovariectomized group implanted with bioactive glass (OVX-BG). An improved mechanical property
was noticed in contact of OVX-BG-Zn (3996 HV) when compared with that of OVX-BG group (2699 HV).
After 90 days of implantation, the histomorphometric analysis showed that trabecular thickness (Tb.Th) and
trabecular number (Tb.N) were significantly increased with 28 and 24%, respectively, in treated rats of OVX-
BG-Zn group as compared to those of OVX-BG groups. Trabecular separation (Tb.Sp) and trabecular bone
pattern factor (TBPf) were significantly decreased in OVX-BG-Zn group with 29.5 and 54% when compared
with those of OVX-BG rat groups. On the other hand, a rise in Ca and P ion concentrations in the implanted
microenvironment was shown and lead to the formation/deposition of Ca-P phases. The ratio of pyridinoline
[Pyr] to dihydroxylysinonorleucine [DHLNL] cross-links was normalized to the control level.
Conclusion: Our findings suggested that BG-Zn might have promising potential applications for osteoporosis
therapy.
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B
one zinc (Zn) content has been shown to decrease
in aging, skeletal unloading, and postmenopausal
conditions, suggesting its role in bone disorders (1).
Zn metal has been demonstrated to have a stimulatory
effect on osteoblastic bone formation and mineralization
(2). Moreover, Zn has been shown to inhibit osteoclastic
bone resorption due to inhibiting osteoclast-like cell for-
mation from bone marrow cells and stimulating apoptotic
cell death of mature osteoclasts (3, 4). Furthermore, it has
been shown to stimulate gene expression of the transcrip-
tion factors runt-related transcription factor 2 (Runx2)
that is related to differentiation into osteoblastic cells (5).
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Postmenopausal osteoporosis is a kind of bone meta-
bolic disease induced by estrogen deficiency. It is char-
acterized by disequilibrium of bone formation and
microarchitecture deterioration (6). Osteoporosis is often
reflected by low bone mineral density (BMD) and fracture
risk and affects the survival of bone marrow stromal cells
and increased bone fragility. Ovariectomized (OVX) animal
model is widely recognized to closely represent the patho-
physiological situations of postmenopausal osteoporosis
(7). Numerous treatments were available for reducing bone
loss but each one had limitations. Despite the benefits
of certain treatments such as selective estrogen receptor
moderators, adverse outcomes such as increased risks for
cancer have been identified (8). Because of their adverse
effects, more attention has been focused on biomaterials
among which, we distinguish bioactive glasses (BGs).
In fact, recently, osteoporotic femur defect was used to
evaluate the therapeutic effect of biomaterials or drug
delivery in skeletal, metabolic, diseased environment, along
with the advantages of easy handling and reliable surgical
reproducibility (9).
BGs have been studied for use in a number of bio-
medical applications, including wound dressings, drug
delivery systems, and other pharmaceutical applications
(1014). Melt-derived BGs are commercially available for
bone repair in powder form (15). The cellular mechanism
in which the BG demonstrates osteogenic response has
been under extensive research. Numerous in vitro studies
have shown that BGs stimulate the growth and maturation
of osteoblasts, and they promote the expression and main-
tenance of the osteoblastic phenotype (16). Moreover, it
has been demonstrated that BG stimulates multipotent
bone marrow stromal cell functions (17). Formation of
the Si-rich layer is known to be a crucial phase in bone
bonding as it acts as a template for calcium phosphate
precipitation (18). The calcium phosphate layer then
directs new bone formation together with absorbing
proteins (19). The extracellular proteins attract macro-
phages, and mesenchymal stem cells and osteoprogenitor
cells. Subsequently, the osteoprogenitor cells proliferate
and differentiate into matrix-producing osteoblasts. In
order to determine whether a new material conforms
to the requirements of biocompatibility and mechanical
stability prior to clinical use, it must undergo rigorous
testing under both initial in vitro and then in vivo
conditions.
Different concentrations of Zn within BGs (BG-1.5 Zn
and BG-5Zn) have been shown to affect bone-associated
cell responses in vitro (20). When implanted in rat cal-
varial defects for 8 weeks, the BG-5Zn scaffolds showed
a significantly better capacity to regenerate bone tissue
compared to the non-doping scaffolds (21). Another
study exhibited the cytocompatibility of a mesoporous
BG scaffold containing 4% ZnO and the addition of Zn
to BG was reported to elicit antimicrobial activity (21).
Our previous studies have been carried out in order to
explore the effects of the BG-Zn biomaterial bioactivities
by using in vitro analysis (22). A bone-like apatite layer
formed on the surfaces of BG-Zn biomaterial after incu-
bation in simulated body fluid (SBF) indicating BG-Zn
bioactivity. The present study aims to investigate the
in vivo antioxidant activity of Zn-doped BG against free
radicals induced by estrogen deficiency, mechanical char-
acterization, and trabecular bone architecture.
Materials and methods
Biomaterial synthesis
For elaboration of BGs, oxides (46 wt% SiO2, 23.94 wt%
CaO, 23.94 wt% Na2O, 6 wt% P2O5, and 0.12 wt% ZnO)
weighed and mixed in a polyethylene bottle for 2 h using a
planetary mixer (23). This content of Zn is close to that of
the human bone. The premixed mixtures were melted in
platinum crucibles that were placed in an electric furnace.
The first rise of temperature rate was 108C/min and it was
held at 9008C for 1 h to achieve the decarbonation of
all products. The second rise of temperature rate was
208C/min and it was held at 1,3508C for 3 h. The samples
were casted in preheated brass cylindrical molds and
annealed at 5658C for 4 h near the glass transition
temperature of each glass. The prepared implants were
sterilized by g-irradiation from a 60 Co Source gamma
irradiation, at a dose of 25 Gy (Equinox, UK), using
standard procedures for medical devices.
Animals
Animal model
Female Wistar rats (1619 weeks of age), obtained from
the Central Pharmacy, Tunisia, and bred in the central
animal house, were used in this study. The rats were
acclimatized to their new environment for 7 days before
the beginning of the study and were fed on a pellet diet
(Sicco, Sfax, Tunisia) and water ad libitum. All of the
animals were kept under climate-controlled conditions
(258C; 55% humidity; 12 h of light alternating with 12 h
of darkness). The Tunisian ethical committee for the care
and use of laboratory animals approved the handling
of the animals. All rats were randomly divided into five
groups (five animals per group). Group I was used as a
negative control without bilateral ovariectomy or surgical
creation of bone defects (CT). Sixty days after bilateral
ovariectomy, Group II was used as a positive control;
Ovariectomized (OVX), whereas, Group III was im-
planted with BG (OVX-BG). The last group (Group
IV) was implanted with BG-Zn (OVX-BG-Zn).
Surgical and postoperative protocol
All surgical interventions were performed under general
anesthesia in aseptic conditions. Anesthesia was induced
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with xylazine (710 mg/kg (i.p.) ROMPUN2%, Merial;
Lyon, France) and ketamine (70100 mg/kg (i.m.) im-
algene†, Merial; Lyon, France) depending on the body
weight. The animals underwent bilateral ovariectomy.
The pre-operative preparation of the surgical sites was
routinely carried out by cleaning with 96% alcohol and
antiseptic solutions (PROLABO; AnalaR Normapur†,
France). A drilled 3-mm-diameter and 4-mm-deep hole
was created on the lateral aspect of the femoral condyle
using a refrigerated drill to avoid necrosis. The resulting
bone defects were irrigated profusely with physiological
saline solution (0.9 wt% NaCl; Ref. 091214; Siphal,
Tunisia) to eliminate bone debris. BGs were implanted in
the form of blocks. The drill hole was filled with 10 mg of
BG and 10 mg of BG-Zn in OVX-BG and OVX-BG-Zn
groups, respectively. The animals were sacrificed 30, 60,
and 90 days postoperatively. The femoral condyles were
exarticulated at the knee joint and freed from all adhering
soft tissues.
Oxidative stress
Tissue preparation and stress oxidative
Thiobarbituric acidreactive substance measurements
The femurs were removed and rapidly frozen by dry ice.
The two tissues of all groups were minced and homo-
genized (100 mg/ml) at 48C in 0.1 mol/l Tris-HCl buffer
pH 7.4 and centrifuged at 3,000 g for 10 min. The im-
planted bone of all groups were minced and homogenized
(100 mg/ml) at 48C in 0.1 mol/l Tris-HCl buffer pH 7.4 and
centrifuged at 3,000 g for 10 min. Lipid peroxidation in
the tissue homogenate was estimated by measuring thio-
barbituric acidreactive substances (TBARS) and was
expressed in terms of malondialdehyde (MDA) content
which is the end product of lipid peroxidation (24).
Antioxidant enzyme studies
Regarding the superoxide dismutase (SOD) activity, it
was assayed by the spectrophotometric method (25).
Glutathione peroxidase (GPx) activity was measured
by the method (26). Catalase (CAT) activity was assayed
calorimetrically at 240 nm and expressed as moles of
H2O2 consumed per minute per milligram of protein (27).
The level of total protein was determined by the method
of Lowry et al. (28) using bovine serum albumin.
Hardness measurement
The hardness was measured by using Vickers Tester.
The Vickers hardness number: HV2Psin (h/2)/D2,
where P is the applied load in kg, D is the mean length
of the diagonals in mm, and h is the angle (1368) between
opposite faces of the Diamond Pyramid. Measurements
are taken after BG and BG-Zn bone implantation.
Histomorphometric evaluation
The implanted femoral condyles were harvested, fixed
in Burdack (formalin), and refrigerated. Specimens were
dehydrated using alcohol titrated solutions from 70 to
100% EtOH. Then, the specimens were infiltrated by
methylmethacrylate that was allowed to polymerize, before
placing it in a mixture of methylmethacrylate (MMA) and
glycolmethacrylate (GMA), without prior decalcification.
Using a sliding microtome (Reichert-Jung), sections of
67 mm thick were debited by cutting along a transverse
plane. Moreover, the sections were stained with modified
Goldner trichrome. The histomorphometric parameters
were measured by a point count method (29) using a
25-point integrating filter.
Determination of bone mineral content using
inductively coupled plasma optical emission
spectrometry
Femurs were dried for 24 h at 658C. Dry bones were
weighed accurately and placed in 25-ml tubes; 2 ml of
nitric acid was added. One milliliter of 30% H2O2 (Sigma)
was placed in the tube after 10 min. The volume of the
mixture was made up to 500 ml with distilled water.
Standard solutions of Ca, P, Si, Zn, and Mg were used
to prepare the working standard solution and a blank
solution. The element concentrations were detected using
inductively coupled plasma optical emission spectrometry
(ICP-OES; Ciros; Spectro Analytical Instrument, Germany).
Cross-link
The newly formed bone was used to analyze the collagen
cross-linking in the bone. The reduction of collagen in the
callus was performed using sodium borohydride (NaBH4,
Sigma-Aldrich Japan K.K., Tokyo, France) and subse-
quent quantification of reducible immature and non-
reducible mature pyridinium cross-links was carried out
by high-performance liquid chromatography (HPLC) as
previously described (30).
Statistical analysis
Statistical analysis was performed using MannWhitney
U-test with SPSS software (Version 17.0). PB0.05 was




As illustrated in Fig. 1ac, the data on the SOD, CAT
and GPx activities in the bone of OVX rats showed a
highly significant decrease when compared to those of
control rats. Also, estrogen deficiency elevated the MDA
levels (Fig. 1d). After 90 days of implantation, OVX-BG
and OVX-BG-Zn groups showed a particular increase
in SOD, CAT, and GPx activities when compared to
OVX group and a significant decrease of MDA levels.
Bone ingrowth by local delivery Zinc from BG
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This positive action was more pronounced in OVX-BG-Zn
than that of OVX-BG. In fact, an increase in the SOD,
CAT, and GPx activities in OVX-BG-Zn with 30, 42, and
20% respectively, was shown at the end of the experiment.
Moreover, a decrease in MDA level by 40% was detec-
ted in OVX-BG-Zn as compared to the OVX-BG group.
A significant enhancement of enzymatic defenses was
observed especially in comparison with OVX group.
A pronounced increase of the SOD, CAT, and GPx
activities by 160, 105 and 320% respectively was shown in
OVX-BG-Zn when compared to the OVX group. In the
same way, an important decrease in MDA level by 40%
was detected.
Biomechanical test
Table 1 shows the results of the hardness measurement
in the femoral condyle bone, BG-Zn-bone and the
BG-bone after 30, 60, and 90 days of implantation. The
BG-Zn-bone hardness measurement exhibited a similar
transitional pattern to that of femoral condyle bone. It
reached even higher levels after 90 days of implantation
and it reached 3996 HV.
Enzymatic cross-links in bone
Fig. 2 shows the content of enzymatic cross-links in the
bone callus before and after bone implantation. At the
newly formed bone site, the total content of enzymatic
cross-links (sum of immature forms and mature forms)
and the total content of immature cross-links (sum of
DHLNL, HLNL, and LNL) of callus bone in ovariecto-
mized groups were significantly lower than in the normal
group. Estrogen deficiency significantly affected the enzy-
matic cross-links of femoral bone. The contents of HLNL
and LNL, which is the immature cross-links, and Dpyr,
Fig. 1. Effects of bioactive glass (BG) and zinc-doped bioactive glass (BG-Zn) on superoxide dismutase (SOD) (a), catalase
(CAT) (b) and glutathione peroxidase (GPx) (c) activities, thiobarbituric acidreactive substances (TBARS) (d) in femoral
condyle bone of ovariectomised female Wistar rats after 90 days. Values are given as means9SE Significantly less enzymatic
activity in the indicated group versus the control group, versus the ovariectomized group (OVX) and #versus the
ovariectomized group and implanted with bioactive glass (OVX-BG), ¥versus the ovariectomized group and implanted with
Zinc doped bioactive glass (OVX-BG-Zn).
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which is a mature crosslink, in the OVX-BG-Zn-treated
group, were significantly higher than that of all other
groups.
ICP-OES of newly formed bone
After ovariectomy, Ca, P, and Zn contents were signifi-
cantly decreased in osteoporotic rats when compared to
those of control group (PB0.01) as illustrated in Table 2,
whereas Mg did not show any significant differences in
OVX-BG-Zn group when compared to those of control
group. After 90 days of OVX-BG-Zn implantation, Ca
concentration in rat femurs was comparable to the con-
trol group and revealed at about 295 mg/g. Similarly, the
P content measurements showed at about 147 mg/g after
90 days in the OVX-BG-Zn group which was comparable
to the control group (143 mg/g). Zn concentrations were
normalized to the initial bone amount and revealed at
about 0.78 mg/g for OVX-BG-Zn group.
Histological analysis
Histological evidence showed a healthy bone of control
rat (Fig. 3a). After 60 days of ovariectomy, the femoral
condyle defect was characterized with a disconnected
trabecular tissue (Fig. 3b). The dominance of the osteoid
and woven bone tissue was shown in contact of the OVX-
BG implanted group (Fig. 3c). After about 90 days, the
dominance of a mineralized tissue after BG-Zn bioma-
terial treatment was noticed (Fig. 3d). In this case, the
implanted OVX-BG-Zn rat bones were compared to a
healthy one without degradation of trabecular connec-
tivity (Fig. 3e). In fact, OVX-BG-Zn was shown to limit
bone loss inducing a beneficial impact on the trabecular
bone microarchitectural properties when compared to
those of OVX-BG-treated rats.
Histomorphometric analysis
After 90 days of implantation, the quantitative analysis
demonstrated that Tb.Th and Tb.N were more signifi-
cantly increased with 28 and 24% respectively, in treated
OVX-BG-Zn group than those of OVX-BG rats. Tb.Sp
and TBPf were significantly decreased in OVX-BG-Zn
group with 29.5 and 54% when compared with that of
OVX-BG rat group (Table 3).
Discussion
Tissue engineeringbased approach represents a promis-
ing alternative for traditional osteoporosis therapies (31).
In this regard, considerable attention has been given to
BGs which are suitable for bone regeneration appli-
cations as they bond with bone and can be tailored to
release therapeutic ions.
In the present study, estrogen deficiency showed that
the bone graft has weakened the antioxidative bone tissue
capacity and led to oxidative stress. In fact, growing
evidence shows that oxidative stress is involved in the
pathogenesis of bone diseases, including osteoporosis
(32). The processes of bone turnover are mediated by
reactive oxygen species (ROS). Oxidative/reductive pro-
cesses are an integral component of bone remodeling;
however, an excessive production and accumulation of
ROS in the bone tissue has detrimental impact on the
bone metabolism (33, 34). ROS decrease bone formation
by the inhibition of osteoblasts generation from osteo-
progenitor cells and by the shortening of their survival
(35). In the present study, after 90 days of implantation,
the antioxidative stress parameters such as SOD, CAT,
and GPx were enhanced following BG-Zn implantation.
These findings suggest that BG-Zn is responsible for the
strong antioxidant effect. In fact, SOD activity is depen-
dent on Zn, Cu, and Mn elements (36, 37). In a recent
study, Zn has been shown to protect from oxidative
protein and DNA damage as well as lipid peroxidation
and caused improvement of the bone tissue oxidative/
antioxidative balance. On the other hand, the investiga-
tion of the mineral profile of the regenerated tissue
showed that the bone remodeling behavior was attributed
to the concentration of ions, such as Ca, P, and Si. In
fact, the dissolution product of Si ion was demonstrated
to promote osseointegration and mineralization in the
initiation stage of bone tissue (36), as well as to facilitate
angiogenesis investigated from both in vitro and in vivo
studies (37). Ca ion can directly activate intracellular
mechanisms by affecting Ca-sensing receptors in osteo-
blastic cells, followed by increasing the expression of
insulin-like growth factors to regulate human osteoblast
proliferation (38). Besides, inorganic phosphate is an-
other essential element for hydroxyapatite deposition and
bone matrix mineralization (39). The in vivo model keeps
determining the true capacity of the improved materials
to be appropriately used for bone regeneration. In the
present study, after 60 days of ovariectomy, the femoral
condyle defect was characterized with a disconnected tra-
becular tissue. Histological evidence showed a weakened
bone after estrogen deficiency. However, BG-Zn adminis-
tration is proposed to prevent the decrease in bone
microarchitecture deterioration and bone loss associated
Table 1. Bone hardness testing after 30, 60, and 90 days of
implantation: ovariectomized rat (OVX), ovariectomized rat
implanted with bioactive glass (OVX-BG), ovariectomized
rat implanted with Zinc-doped bioactive glass (OVX-BG-Zn)
Hardness test (HV) 30 days 60 days 90 days
Control 3796§,¥,$ 3898§,¥ 3897§,¥
OVX 891*,¥,$ 994*,¥,$ 892*,¥,$
OVX-BG 2594*,§,$ 2692*,§,$ 2699*,§,$
OVX-BG-Zn 4197¥,§ 4091¥,§ 3996§,¥
*pB0.01 vs. control; §pB0.01 vs. OVX group; ¥pB0.01 vs. OVX-
BG group; $pB0.01 vs. OVX-BG-Zn group. Values are expressed
as means9SD of five rats.
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with postmenopausal osteoporosis. This in vivo study has
a special focus on understanding the effect of Zn ion
doping into BGs on mechanical properties. In vivo, it is
important that the biomaterial exhibits adequate mecha-
nical strength because bone is under continuous stress (40).
Thus, ideally the strength of implanted cellbiomaterial
Table 2. Distribution of Ca, P, Si, Zn, and Mg in control rat, ovariectomized rat (OVX), ovariectomized rat implanted with
bioactive glass (OVX-BG), ovariectomized rat implanted with Zinc-doped bioactive glass (OVX-BG-Zn)
Ca (mg) P (mg) Si (mg) Zn (mg) Mg (mg)
CT 310.009110 143.00967 27.00911 0.6890.2 4.790.19
OVX 200.00970*, 110.00970*, 20.0099.0 0.2290.08*, 1.2890.50*,
OVX-BG 252.00998*, 142.10950 57.05920* 0.2790.04*, 3.9991.0
OVX-BG-Zn 295.009130 147.70962 58.10919* 0.7890.05 4.990.70
*pB0.01 vs. control; pB0.01 vs. OVX-BG-Zn group. Values are expressed as means9SD of five rats.
Fig. 2. Comparison of the contents of enzymatic collagen cross-links in femur of control rat, ovariectomized rat (OVX),
ovariectomizd and implanted with bioactive glass (OVX-BG), ovariectomizd and implanted with Zinc doped bioactive glass
(OVX-BG-Zn) *Significantly less enzymatic activity in the indicated group versus the control group, versus the ovariectomized
group (OVX) and #versus the ovariectomized group and implanted with bioactive glass (OVX-BG), ¥versus the ovariectomized
group and implanted with zinc-doped bioactive glass (OVX-BG-Zn).
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construct should match that of living bone (41). The
present study underscores that the Zn ion doping into
BG network is a potential approach to enhance the
mechanical properties. One of the explanations regarding
mechanical enhancement is that after in vivo contact,
a formation of thin needles of hydroxyapatite entangled
in the matrix was detected (42). In addition, BG-Zn
increased the enzymatic cross-links in postmenopausal
osteoporosis model. Of particular interest, in the BG-Zn-
treated group, there was a high correlation between
mechanical properties and enzymatic collagen cross-links,
suggesting that an improvement in mechanical strength
by BG-Zn administration is closely associated with an
increase in enzymatic cross-links. In fact, bone quality is
prescribed by the characteristic of the matrix (material
quality) and the structural characteristic of bone. Material
quality, including collagen cross-linking, plays an impor-
tant role in the reinforcement of bone strength. In bone,
enzymatic cross-links are considered to be beneficial
because they have a positive effect on the physiological
functions of bone. It was reported that Zn regulates
collagen cross-linking and copper/zinc SOD causes bone
fragility owing to low-turnover osteoporosis and im-
paired collagen cross-linking. Recently, it was observed
that, in hip fracture, lysine hydroxylation of collagen
chains increased, which was associated with significantly
higher values of Pyr/Dpyr (43). In the present osteopo-
rotic animal model, Zn may play a fundamental role in
the collagen cross-linking process stability.
Conclusion
This study demonstrated that synthesized BG-Zn can
be used as bone substitutes for local implantation into
osteoporotic defects. In fact, the antioxidative stress para-
meters such as SOD, CAT, and GPx were enhanced after
90 days of implantation. The BG-Zn-bone hardness
measurement exhibited a similar transitional pattern to
that of femoral condyle bone. The histomorphometric
parameters such as Tb.Th, Tb.N, Tb.Sp, and TBPf showed
a significant amelioration. Concerning the enzymatic cross-
links, the contents of HLNL and LNL, which is the im-
mature cross-links, and Dpyr, which is a mature crosslink,
were significantly enhanced in the OVX-BG-Zn-treated
group. The investigation of the mineral profile of the
regenerated tissue showed the deposition of significant
amounts of mineralized matrix with a significant increase
Fig. 3. The control groups in healthy bone (a), disconnected
trabecular tissue in ovariectomized rat bone (b). Woven bone
in OVX-BG group (c), mineralized bone implanted with
BG-Zn in OVX-BG-Zn implanted group (d), and connected
trabecular tissue in the OVX-BG-Zn implanted group after
90 days of implantation (e). (a, b and c, d, e Goldner’s
trichrome staining) (10 objective, scale bar20 mm).
Table 3. Determination of (Tb.Pf), (Tb.Th), (Tb.N), and (Tb.Sp) after 90 days in control femoral condyle Wistar rats (CT),
ovariectomized rats (OVX), ovariectomized rat implanted with bioactive glass (OVX-BG), ovariectomized rat implanted with
Zinc-doped bioactive glass (OVX-BG-Zn)
Tb.Pf (/mm) Tb.Th (mm) Tb.N (/mm) Tb.Sp (mm)
Control 4.191§ 176925§,¥ 1.290.4§ 1,2409320§,¥
OVX 9.592*,¥,$ 123930*,¥,$ 0.690.09*,¥,$ 1,8039530*,§,¥,$
OVX-BG 7.491§,$ 132940*,§,$ 0.8790.09§,$ 1,6849325*,§,$
OVX-BG-Zn 4.891.55§,¥ 169962§,¥ 1.0890.09 1,3009400§,¥
*pB0.01 vs. control; §pB0.01 vs. OVX group; ¥pB0.01 vs. OVX-BG group; $pB0.01 vs. OVX BG-Zn group. Values are expressed as
means9SD of five rats.
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in Ca-P layer. These data suggest the BG-Zn therapeutic
approaches to bone diseases.
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